Somebody needs to give Von der Cuntface a shot of led behind the ear.
EU nations forced to pay for von der Leyenās Covid deal
A Belgian court has ordered Poland and Romania to buy $2.2 billion worth of Covid-19 vaccines from Pfizer and BioNTech
Published 2 Apr, 2026 19:19
FILE PHOTO: European Commission President Ursula von der Leyen. Ā© Global Look Press / Lyu You
Poland and Romania have to fulfill their obligations under an EU deal and buy ā¬1.9 billion ($2.2 billion) worth of unneeded Covid-19 vaccines from Pfizer and BioNTech, a Belgian court has ruled.
The case is linked to the agreements struck by Brussels at the height of the pandemic. European Commission President Ursula von der Leyen has faced criticism over her role in the controversial deals.
At the time, the commission advocated collectively purchasing billions of shots and distributing them among EU member states struggling to contain Covid-19. It ended up signing multibillion-euro deals with vaccine manufacturers in 2020 and 2021.
Poland refused to comply with its part of the contract in 2022, pointing to an improving situation with Covid and potential abuse of its dominant position by Pfizer. Romania followed suit soon thereafter. The US pharma giant filed a lawsuit against both nations in 2023.
The Brussels court rejected the defendantsā arguments in its verdict and ruled that the decrease in the infection rate did not justify the
āmodificationā of contractual obligations.
Under the ruling, Poland would have to buy Pfizer vaccines worth ā¬1.3 billion while Romania would have to purchase shots worth ā¬600 million.
Warsaw said it would
āpursue all legal remedies available to it to amend this ruling and defend its interests.ā Bucharest stated that the requested sum amounts to
āthe equivalent of ā a ... regional hospital in Romaniaā and also vowed to appeal the decision.
The controversial EU vaccine deal led to the so-called Pfizergate scandal, in which the European Commission and von der Leyen personally were accused of concealing details of negotiations with Pfizer and AstraZeneca.
Von der Leyen was particularly criticised for her refusal to disclose or preserve key text messages she supposedly exchanged with Pfizer CEO Albert Bourla. The issue even prompted a no-confidence motion in the EU Parliament last year, which she ultimately survived.
A Belgian court has sided with the US pharma giant Pfizer in its demand for Warsaw and Bucharest to honor the deal struck by the EU
www.rt.com